-->

Smith Nephew Plc Stock Current Valuation

Valuation analysis of Smith Nephew plc helps investors to measure Smith Nephew's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.

Smith Nephew plc Company Current Valuation Analysis

Smith Nephew's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Smith Nephew Current Valuation

    
  14.08 B  
Most of Smith Nephew's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Smith Nephew plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Smith Nephew plc has a Current Valuation of 14.08 B. This is 2.0% lower than that of the Healthcare sector and 13.3% higher than that of the Medical Devices industry. The current valuation for all United States stocks is 15.33% higher than that of the company.

Smith Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Smith Nephew's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Smith Nephew could also be used in its relative valuation, which is a method of valuing Smith Nephew by comparing valuation metrics of similar companies.
Smith Nephew is currently under evaluation in current valuation category among its peers.

Smith Fundamentals

About Smith Nephew Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Smith Nephew plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Smith Nephew using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Smith Nephew plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Smith Pink Sheet

Smith Nephew financial ratios help investors to determine whether Smith Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Smith with respect to the benefits of owning Smith Nephew security.